Description
The spike protein (S protein) of the pandemic coronavirus (SARS-CoV-2) is the antigen of choice for use in vaccines and serological diagnostic tests. There is thus a pressing need to develop a robust bioprocess allowing scale-up of spike pr…
Amendment chain · 2 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $492,387 at start, $492,387 after amendment #1 (+$0).
- #02021-02-07$492,387
- #12022-01-20$492,387
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2021-02-07(start date) | $492,387 | — | The spike protein (S protein) of the pandemic coronavirus (SARS-CoV-2) is the antigen of choice for use in vac… |
| #1 amendment | 2022-01-20 | $492,387 | +$0 | The spike protein (S protein) of the pandemic coronavirus (SARS-CoV-2) is the antigen of choice for use in vac… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 107585226)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 018-2026-2027-Q1-06-MN5-036 | National Defence | Défense nationale · Innovation for Defence Excellence and Security Program | $997,600 | FY2027 |
| 172-2025-2026-Q4-1041061 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives | $349,971 | FY2026 |
| 012-2025-2026-Q4-01464 | Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec · REGI-RDII - Regional Defence Investment Initiative - Ecosystem | $655,000 | FY2026 |
| 172-2025-2026-Q4-1040351 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program – Ideation Fund | $24,483 | FY2026 |
| 207-2025-2026-Q4-00866 | Social Sciences and Humanities Research Council of Canada | Conseil de recherches en sciences humaines du Canada · Insight research | $50,000 | FY2026 |
| 172-2025-2026-Q3-1034968 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives | $387,338 | FY2026 |
Other recipients funded under "Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2026-2027-Q1-1044103 | York University | FY2027 | $462,000 | FY2027 |
| 172-2026-2027-Q1-1043787 | Simon Fraser University | FY2027 | $279,766 | FY2027 |
| 172-2026-2027-Q1-1044229 | Noram Electrolysis Systems Inc. | FY2027 | $300,053 | FY2027 |
| 172-2026-2027-Q1-1043305 | University of Ottawa | FY2027 | $418,000 | FY2027 |
| 172-2026-2027-Q1-1043602 | University of Windsor | FY2027 | $99,000 | FY2027 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2020-2021-Q4-965937 · retrieved 2026-11-14.